Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2003
06/05/2003WO2003046149A2 Methods of using improved polymerases
06/05/2003WO2003046147A2 Novel human g-protein coupled receptor, hgprbmy31, and variants and methods of use thereof
06/05/2003WO2003046139A2 CRBs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHOD OF USE
06/05/2003WO2003046137A2 Hiv envelope v3-ccr5 binding site immunogen
06/05/2003WO2003046135A2 Osteopontin-related compositions and methods
06/05/2003WO2003046134A2 Expression of polypeptides in rod outer segment membranes
06/05/2003WO2003046133A2 Regulatory nucleic acid assay for diagnostic and library screens
06/05/2003WO2003046131A2 Dnmt3l-related cloning and reproductive methods
06/05/2003WO2003046129A2 Compositions for the derivation of germ cells from stem cells and methods of use thereof
06/05/2003WO2003046127A2 Tumor endothelial marker 5 molecules and uses thereof
06/05/2003WO2003046125A2 Hin-2 nucleic acid molecules, proteins, antibodies, homologues, receptors, and uses thereof
06/05/2003WO2003046124A2 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
06/05/2003WO2003046123A2 Mutated gene from corynebacterium glutamicum
06/05/2003WO2003046013A1 Fusion protein having enhanced in vivo activity of erythropoietin
06/05/2003WO2003046012A1 Antigen presenting cell targeting conjugate, an antigen presenting cell contacted with such conjugate, their use for vaccination or as medicament, and methods for their production or generation
06/05/2003WO2003046011A1 Antigen presenting cell targeting conjugate an antigen presenting cell contacted with such conjugate their use for vaccination or as medicament and methods for their production or generation
06/05/2003WO2003046010A1 Inter alpha trypsin inhibitor biopolymer markers indicative of insulin resistance
06/05/2003WO2003046006A1 Polynucleotides encoding nexin-related serine protease inhibitor
06/05/2003WO2003046005A2 Interalpha trypsin inhibitor biopolymer markers indicative of insulin resistance
06/05/2003WO2003046004A2 Macroglobulin biopolymer markers indicative of insulin resistance
06/05/2003WO2003046003A2 Plasma protease c1 biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046002A1 Lactoferricin gene and transformant expressing lactoferricin
06/05/2003WO2003046001A2 Protein biopolymer markers predictive of insulin resistance
06/05/2003WO2003046000A2 Apolipoprotein biopolymer markers predictive of insulin resistance
06/05/2003WO2003045999A2 Human vanilloid receptor protein and polynucleotide sequence encoding same
06/05/2003WO2003045998A2 Polynucleotide and protein involved in synaptogenesis, variants thereof, and their therapeutic and diagnostic uses
06/05/2003WO2003045997A2 Fusion proteins containing tlp peptides
06/05/2003WO2003045996A1 Chromatographic purification of recombinant human erythropoietin
06/05/2003WO2003045995A2 Cell culture process
06/05/2003WO2003045994A1 Novel ligand and dna thereof
06/05/2003WO2003045993A2 Protein biopolymer markers predictive of type ii diabetes
06/05/2003WO2003045992A1 Cenp-e biopolymer marker indicative of age matched control
06/05/2003WO2003045991A2 Complement c3 precursor biopolymer markers predictive of alzheimers disease
06/05/2003WO2003045990A2 Protein-protein interactions involving transforming growth factor beta signalling
06/05/2003WO2003045989A1 A novel homeobox gene
06/05/2003WO2003045988A2 Method to isolate genes involved in aging
06/05/2003WO2003045987A2 A food grade lantibiotic from streptococcus macedonicus and uses thereof
06/05/2003WO2003045986A2 Purified polypeptides involved in general metabolism as possible drug targets
06/05/2003WO2003045985A2 Purified polypeptides involved in carbohydrate and coenzyme metabolism
06/05/2003WO2003045984A2 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance
06/05/2003WO2003045983A1 Apolipoprotein biopolymer markers predictive of type ii diabetes
06/05/2003WO2003045980A2 Glycopeptide remodeling using amidases
06/05/2003WO2003045973A2 Peptides with growth inhibitory action
06/05/2003WO2003045970A1 Novel molecules of the card related protein family and uses thereof
06/05/2003WO2003045499A1 METHODS RELATED TO AN α4 NICOTINIC ACETYLCHOLINE RECEPTOR SUBUNIT MUTANT
06/05/2003WO2003045440A1 Regulation of hypoxia-inducible gene expression with antisense inhibitory pas domain protein
06/05/2003WO2003045439A1 Genetic remedies for neurodegenerative diseases
06/05/2003WO2003045429A2 Anti-t cell immunotoxin fusion protein and its therapeutic use
06/05/2003WO2003045425A1 Muscle transcription factors
06/05/2003WO2003045420A2 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization
06/05/2003WO2003045320A2 Somatostatin analog and uses thereof
06/05/2003WO2003045318A2 Manipulation of cytokine levels using cd83 gene products
06/05/2003WO2003045317A2 Therapeutic protein and treatments
06/05/2003WO2003045230A2 Novel compositions and methods for cancer
06/05/2003WO2003045136A1 Disruption of the prostaglandin e synthase 2 gene
06/05/2003WO2003045128A2 SYNTHETIC IMMUNOGENIC BUT NON-DEPOSIT-FORMING POLYPEPTIDES AND PEPTIDES HOMOLOGOUS TO AMYLOID β, PRION PROTEIN, AMYLIN, α-SYNUCLEIN, OR POLYGLUTAMINE REPEATS FOR INDUCTION OF AN IMMUNE RESPONSE THERETO
06/05/2003WO2003027288A9 Diagnostic method for cancer characterized in the detection of the deletion of g-csf exon 3
06/05/2003WO2003017032A3 Computer-based methods of designing molecules
06/05/2003WO2003010201A9 Blood group antigen fusion polypeptides and methods of use thereof
06/05/2003WO2003010197A3 Gmg-1 polynucleotides and polypeptides and uses thereof
06/05/2003WO2003006502A3 Isolation, characterization, and use of a teleost potassium channel
06/05/2003WO2003004526A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses and their use as medicines
06/05/2003WO2003000296A3 Treatment and diagnostic of b cell chronic lymphocytic leukaemia
06/05/2003WO2002102843A3 Gene expression during meningococcus adhesion
06/05/2003WO2002102306A3 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy
06/05/2003WO2002086072A3 Antimicrobial polypeptides and their uses
06/05/2003WO2002083912A3 Production of apomictic seed
06/05/2003WO2002083843A3 Outer membrane associated polypeptides
06/05/2003WO2002077261A3 Human potassium channel
06/05/2003WO2002072761A9 Polypeptides interactive with bcl-x¿l?
06/05/2003WO2002070704A3 Adipocyte complement related protein zacrp11
06/05/2003WO2002070542A3 Band 3 antigenic peptides, malaria polypeptides and uses thereof
06/05/2003WO2002062841A3 Secreted proteins
06/05/2003WO2002060946A3 Methods and compositions relating to cardiac-specific nuclear regulatory factors
06/05/2003WO2002060932A3 A serpin in bifidobacteria
06/05/2003WO2002059307A3 Human ltrpc7 proteins, nucleic acid molecules encoding them, and uses thereof
06/05/2003WO2002055684A3 Synthetic proteins containing a protein transduction domain
06/05/2003WO2002048183A3 Compositions of peptide crystals
06/05/2003WO2002046420A3 Nebulin-related protein
06/05/2003WO2002046392A3 X ray crystal structures at 5.5 a resolution of functional complexes of the bacterial ribosome containing transfer rna and model messenger rnas
06/05/2003WO2002046230A3 G-protein coupled receptors
06/05/2003WO2002042479A3 Polynucleotides encoding defense response proteins
06/05/2003WO2002042330A3 Cystoskeleton-associated proteins
06/05/2003WO2002040673A3 Compositions and methods relating to lung specific genes and proteins
06/05/2003WO2002036620A3 Ets-transcription factor related compound specific promoter and transactivators thereof
06/05/2003WO2002036075A3 Small molecule compositions for binding to hsp90
06/05/2003WO2002030965A3 Nucleic acids encoding stichodactylidae chromoproteins
06/05/2003WO2002028898A3 Regulation of human secretin receptor-like gpcr
06/05/2003WO2002014478A3 IMMUNOGENIC HBc CHIMER PARTICLES HAVING ENHANCED STABILITY
06/05/2003WO2002007754A3 New use
06/05/2003US20030106107 Genes encoding plant transcription factors
06/05/2003US20030106105 Promoter expressed specifically in the cells of plant roots, recombinant vectors and host cells comprising same and transgenic plants obtained
06/05/2003US20030106104 Antiapoptosis; antisense agents; regulation of seed aging in tomatoes; stress resistance; prolonged viability and shelf-life
06/05/2003US20030106103 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
06/05/2003US20030106102 Antiapoptosis; antisense agents; regulation of seed aging in tomatoes; stress resistance; prolonged viability and shelf-life
06/05/2003US20030106101 Antiapoptosis; antisense agents; regulation of seed aging in tomatoes; stress resistance; prolonged viability and shelf-life
06/05/2003US20030106100 DNA molecules encoding enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing these molecules
06/05/2003US20030106095 Glucocerebrosidases; galactosidases; treatment for Gaucher's disease
06/05/2003US20030106093 Coleoptera resistant plants; biological pest control
06/05/2003US20030106089 Cotton fiber transcriptional factors
1 ... 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 ... 2916